Real-time CGM Support to Help Adults Manage Type 2 Diabetes
Official title: Real-time Insights for Smart Engagement with CGM (RISE-CGM)
Funded at Healthpartners Institute · NIH-11447761 · Data updated 2026-11-12
A 28-week digital program helps adults with type 2 diabetes use real-time CGM data and tailored guidance to build healthier eating and lifestyle habits.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Healthpartners Institute NIH-funded |
| Lab location | 1 site (Bloomington, UNITED STATES) |
| Project start | July 15, 2026 |
| Project end | May 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $314,000 |
| NIH project number | 1R01DK145690-01A1 |
| Project ID | NIH-11447761 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults 21+ with type 2 diabetes who use a CGM and are willing to participate in a 28-week program with follow-up.
✕Less likely to help
If you do not use CGM or have other medical conditions that require different diabetes management, this program may not be suitable for you.
What this research studies
If you have type 2 diabetes, this program uses your real-time glucose data from a CGM and simple, science-based lifestyle coaching over 16 weeks, followed by 12 weeks of support to keep you on track. It’s designed to be scalable and easily integrated into daily life, with education on how foods and activities affect glucose. Participation would involve engaging with digital tools and guidance to adopt lasting behavior changes aimed at better blood sugar control. The goal is to help you understand and use CGM feedback to make healthier choices that could improve your long-term outcomes.
Why it matters
Potential benefit: If successful, this program could help you maintain better blood sugar levels and adopt sustainable lifestyle changes.
How similar studies have gone: Prior digital behavior change interventions have shown modest improvements in glycemic outcomes, supporting the potential for this approach.
Where this research is happening
-
Healthpartners Institute
Bloomington, United States Active
Researchers
- Principal investigator: Hooker, Stephanie a — Healthpartners Institute
- Study coordinator: Hooker, Stephanie a
Related research
Other NIH-funded projects on the same topics.
-
Mitigating DKA in people with type 1 diabetes and kidney disease using SGLT1/2 inhibitors
This project tests a new way to prevent dangerous diabetic ketoacidosis in people with type 1 diabetes and chronic kidney disease who are using SGLT inhibitors, by tracking ketones in real time and combining glucose-keton data for safer therapy.
-
Metro-Minnesota community cancer care research network
A nationwide cancer research program is testing real-world care approaches across community hospitals in the Twin Cities to improve cancer treatment and outcomes.
-
ENDS and tobacco policy: how policy choices affect tobacco-related harms
This project looks at how electronic nicotine delivery systems (ENDS) and different tobacco policies shape the overall harms from tobacco for the population.
-
Artificial intelligence to support ED decision-making
A large NIH-funded project aims to help emergency department teams make faster, safer triage decisions using AI tools and language models.
-
MAP to Health: a digital program to help adults stay physically active
A digital program uses personal meaning and self-determination-based support to help adults 21+ stay physically active over time.
-
Metro‑Minnesota Community Cancer Network
Brings National Cancer Institute treatment, prevention, and care‑delivery clinical trials to people getting cancer care in community hospitals and clinics around Minneapolis–St. Paul.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.